S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
CVE:EMH

Emerald Health Therapeutics (EMH) Stock Forecast, Price & News

C$0.26
-0.01 (-3.77%)
(As of 04/26/2021)
Compare
Today's Range
C$0.25
▼
C$0.27
50-Day Range
C$0.26
▼
C$0.26
52-Week Range
C$0.15
▼
C$0.53
Volume
384,329 shs
Average Volume
644,760 shs
Market Capitalization
C$52.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsInsider TradesHeadlines

EMH stock logo

About Emerald Health Therapeutics (CVE:EMH) Stock

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Receive EMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EMH Stock News Headlines

May 4, 2023 | health.usnews.com
Emerald Care Center Tulsa
April 25, 2023 | health.usnews.com
Emerald Reeg
June 9, 2023 | Legacy Research (Affiliate) (Ad)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
March 14, 2023 | msn.com
Emerald Expositions GAAP EPS of $0.06, revenue of $93.6M
March 13, 2023 | sfgate.com
Tahoe's Emerald Bay freezes over for first time in decades amid atmospheric river
March 4, 2023 | venturebeat.com
Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference
January 14, 2023 | finance.yahoo.com
Emerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Year
January 4, 2023 | finance.yahoo.com
Emerald Health Therapeutics Inc (TBD.BE)
June 9, 2023 | Legacy Research (Affiliate) (Ad)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
July 12, 2022 | finance.yahoo.com
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order
June 16, 2022 | finance.yahoo.com
Emerald Health Therapeutics Provides Bi-Weekly MCTO Status Update
May 16, 2022 | stockhouse.com
Emerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Update
May 12, 2022 | nz.finance.yahoo.com
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
January 5, 2022 | investing.com
Emperor Oil Ltd (EMh)
December 31, 2021 | ca.finance.yahoo.com
Stocks in play: Emerald Health Therapeutics Inc
December 31, 2021 | stockhouse.com
Emerald Health Therapeutics Reports 2021 AGM Results
November 29, 2021 | msn.com
Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals
November 29, 2021 | finance.yahoo.com
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
August 6, 2021 | news.yahoo.com
Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
May 25, 2021 | ca.finance.yahoo.com
Emerald Health Therapeutics Signs Letter of Intent for Product Co-Development Agreement with Prima Botanical Wellness Brand
May 3, 2021 | ca.finance.yahoo.com
Emerald Health Therapeutics Reports 2020 Year-end and Fourth Quarter Financial Results and Provides Corporate Update
December 17, 2020 | reuters.com
Avricore Health Inc
December 1, 2020 | stockhouse.com
Emerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
November 2, 2020 | law360.com
Canadian Greenhouse Co. Takes Over Pot Venture For $60M
September 1, 2020 | seekingalpha.com
Emerald Health Therapeutics, Inc. (EMHTF) CEO Riaz Bandali on Q2 2020 Results - Earnings Call Transcript
August 25, 2020 | au.finance.yahoo.com
EMERALD HEALTH THER. (TBD.BE)
August 3, 2020 | stockhouse.com
Emerald Health Therapeutics Announces Stock Option Grant
See More Headlines

EMH Price History

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
CVE:EMH
CUSIP
N/A
CIK
N/A
Web
www.emerald.care
Phone
+1-250-8189838
Fax
N/A
Employees
161
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
35.45
Current Ratio
2.97
Quick Ratio
2.61

Sales & Book Value

Annual Sales
C$13.02 million
Price / Sales
4.02
Cash Flow
C$0.33 per share
Price / Cash Flow
0.78
Book Value
C$0.40 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
205,028,000
Free Float
N/A
Market Cap
C$52.28 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Avtar S. Dhillon (Age 59)
    Exec. Chairman
    Comp: $485.05k
  • Mr. Riaz Bandali M.B.A. (Age 51)
    CEO & Pres
    Comp: $428.21k
  • Ms. Jenn Hepburn B.B.A.
    CFO & Company Sec.
  • Mr. Orville Bovenschen
    Sr. VP of Operations
  • Mr. Bernie Hertel
    VP of Fin. and Communications
  • Ms. Rebecca Wong
    Sr. VP of Quality & Regulatory Affairs

Key Competitors

View All Competitors













EMH Stock - Frequently Asked Questions

How have EMH shares performed in 2023?

Emerald Health Therapeutics' stock was trading at C$0.26 at the beginning of the year. Since then, EMH shares have increased by 0.0% and is now trading at C$0.26.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Alibaba Group (BABA), Micron Technology (MU), CRISPR Therapeutics (CRSP), Charlotte's Web (CWBHF), Organigram (OGI), Emerald Health Therapeutics (EMHTF).

What is Emerald Health Therapeutics' stock symbol?

Emerald Health Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EMH."

How do I buy shares of Emerald Health Therapeutics?

Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Emerald Health Therapeutics' stock price today?

One share of EMH stock can currently be purchased for approximately C$0.26.

How much money does Emerald Health Therapeutics make?

Emerald Health Therapeutics (CVE:EMH) has a market capitalization of C$52.28 million and generates C$13.02 million in revenue each year.

How many employees does Emerald Health Therapeutics have?

The company employs 161 workers across the globe.

How can I contact Emerald Health Therapeutics?

Emerald Health Therapeutics' mailing address is 4420 West Saanich Road, Rpo Royal Oak PO Box 24076, VICTORIA, BC V8Z 7E7, Canada. The official website for the company is www.emerald.care. The company can be reached via phone at +1-250-8189838.

This page (CVE:EMH) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -